Recursion Pharmaceuticals
RXRX
#4150
Rank
$1.96 B
Marketcap
$8.28
Share price
-6.65%
Change (1 day)
-5.59%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2023 (TTM): -$0.34 B

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.36 B. In 2022 the company made an earning of -$0.24 B a decrease over its 2021 earnings that were of -$0.19 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -$0.34 B38.68%
2022 -$0.24 B30.46%
2021 -$0.19 B114.28%
2020 -$85.65 M